Roland Gamsjaeger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Roland Gamsjaeger has a total of 229 co-authors. Here are the top co-authors by number of shared publications:
- Joel P. Mackay
School of Life and Environmental Sciences, University of Sydney, Sydney, NSW, Australia
17 shared publications - Liza Cubeddu
School of Science, Faculty of Engineering, Computing and Science, Western Sydney University, Penrith, NSW, 2751, Australia.
15 shared publications Liza Cubeddu
School of Science, Faculty of Engineering, Computing and Science, Western Sydney University , Penrith, NSW 2751
13 shared publications- Derek J. Richard
School of Biomedical Sciences, Centre for Genomics and Personalised Health, Queensland University of Technology (QUT), Kelvin Grove, Australia
10 shared publications - Ann Hau-Yu Kwan
School of Life and Environmental Sciences, Faculty of Science, Darlington, The University of Sydney , NSW 2006
9 shared publications Ruvini Kariawasam
School of Science and Health, Western Sydney University, Penrith, New South Wales, Australia
9 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (21)
Conformationally heterogeneous RNA stem-loops enable dimerization-assisted assembly of SARS-CoV-2 Nsp9
SARS-CoV-2 non-structural protein 9 (Nsp9) is an essential RNA-binding protein, yet the physical principles governing its RNA recognition remain poorly defined. Using NMR spectroscopy, small-angle X-ray scattering, dynamic light scattering, cell imaging, and viral yield-reduction assays, we show that Nsp9 preferentially engages conformationally heterogeneous RNA stem-oops and assembles through dimerization-assisted, multivalent interactions. Structured stem-loops with well-defined conformations and extended single-stranded RNAs exhibit only weak, localized binding. In contrast, the stem-loop-rich host 7SL S domain engages an extended interaction surface across the Nsp9 dimer. A 20-nt RNA hairpin bearing phosphorothioate and 2′-O-methyl modifications recapitulates this binding behaviour and promotes concentration-dependent formation of higher-order Nsp9 assemblies. NMR analysis indicates that this RNA retains stem-loop structure while populating a broader conformational ensemble than its unmodified counterpart. Disrupting the conserved GxxxG dimerization motif weakens binding and reduces assembly formation, demonstrating that dimerization assists integration of multiple weak RNA contacts into a cooperative interface. In cells, the modified RNA colocalizes with Nsp9 in cytoplasmic puncta and inhibits SARS-CoV-2 replication with nanomolar potency. Together, these results identify RNA conformational ensembles as important determinants of Nsp9 recognition, and suggest that RNA backbone modification can be used to engineer RNA-protein interactions through control of RNA conformational behaviour.
- 10 November 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (21)
Open AccessConformationally heterogeneous RNA stem-loops enable dimerization-assisted assembly of SARS-CoV-2 Nsp9
SARS-CoV-2 non-structural protein 9 (Nsp9) is an essential RNA-binding protein, yet the physical principles governing its RNA recognition remain poorly defined. Using NMR spectroscopy, small-angle X-ray scattering, dynamic light scattering, cell imaging, and viral yield-reduction assays, we show that Nsp9 preferentially engages conformationally heterogeneous RNA stem-oops and assembles through dimerization-assisted, multivalent interactions. Structured stem-loops with well-defined conformations and extended single-stranded RNAs exhibit only weak, localized binding. In contrast, the stem-loop-rich host 7SL S domain engages an extended interaction surface across the Nsp9 dimer. A 20-nt RNA hairpin bearing phosphorothioate and 2′-O-methyl modifications recapitulates this binding behaviour and promotes concentration-dependent formation of higher-order Nsp9 assemblies. NMR analysis indicates that this RNA retains stem-loop structure while populating a broader conformational ensemble than its unmodified counterpart. Disrupting the conserved GxxxG dimerization motif weakens binding and reduces assembly formation, demonstrating that dimerization assists integration of multiple weak RNA contacts into a cooperative interface. In cells, the modified RNA colocalizes with Nsp9 in cytoplasmic puncta and inhibits SARS-CoV-2 replication with nanomolar potency. Together, these results identify RNA conformational ensembles as important determinants of Nsp9 recognition, and suggest that RNA backbone modification can be used to engineer RNA-protein interactions through control of RNA conformational behaviour.
- Open Access
- 16 May 2026
- Published by Springer Nature in Biomolecular NMR Assignments
- Vol. 20 (1)
Backbone resonance assignment of the third domain of the human staphylococcal nuclease domain-containing protein 1 (SND1)
Staphylococcal nuclease and Tudor domain‑containing protein 1 (SND1) is a multifunctional RNA‑binding protein implicated in transcriptional regulation, post‑transcriptional RNA control, oncogenesis, and viral infection. Initially identified as a transcriptional coactivator, SND1 was later established as a component of the RNA‑induced silencing complex, where it contributes to RNA turnover and microRNA regulation. SND1’s diverse activities stem from its modular architecture, comprising four staphylococcal nuclease‑like domains, capable of direct RNA binding, and an extended Tudor domain that together form an integrated RNA‑binding and catalytic platform. This versatility also underlies its role in viral infection: SND1 acts as an m⁶A reader and is exploited by RNA viruses, such as SARS‑CoV‑2. Recent work showed that SND1 depletion, particularly loss of its third structured domain (SN3), reduces recruitment of the viral protein Nsp9 to the 3′ untranslated region of the SARS‑CoV‑2 genome, impairing viral RNA synthesis through a direct SN3–Nsp9 interaction. Here, we report expression, purification, and near‑complete backbone NMR assignments of the SN3 domain of SND1. Secondary structure elements calculated by TALOS-N based on these assignments are in good agreement with the existing crystal structure of SN3. Our data provide an excellent foundation for future structural studies of SND1–RNA complexes and their roles in viral RNA priming in SARS-CoV-2.
- 16 May 2026
- Published by Springer Nature in Biomolecular NMR Assignments
- Vol. 20 (1)
Open AccessBackbone resonance assignment of the third domain of the human staphylococcal nuclease domain-containing protein 1 (SND1)
Staphylococcal nuclease and Tudor domain‑containing protein 1 (SND1) is a multifunctional RNA‑binding protein implicated in transcriptional regulation, post‑transcriptional RNA control, oncogenesis, and viral infection. Initially identified as a transcriptional coactivator, SND1 was later established as a component of the RNA‑induced silencing complex, where it contributes to RNA turnover and microRNA regulation. SND1’s diverse activities stem from its modular architecture, comprising four staphylococcal nuclease‑like domains, capable of direct RNA binding, and an extended Tudor domain that together form an integrated RNA‑binding and catalytic platform. This versatility also underlies its role in viral infection: SND1 acts as an m⁶A reader and is exploited by RNA viruses, such as SARS‑CoV‑2. Recent work showed that SND1 depletion, particularly loss of its third structured domain (SN3), reduces recruitment of the viral protein Nsp9 to the 3′ untranslated region of the SARS‑CoV‑2 genome, impairing viral RNA synthesis through a direct SN3–Nsp9 interaction. Here, we report expression, purification, and near‑complete backbone NMR assignments of the SN3 domain of SND1. Secondary structure elements calculated by TALOS-N based on these assignments are in good agreement with the existing crystal structure of SN3. Our data provide an excellent foundation for future structural studies of SND1–RNA complexes and their roles in viral RNA priming in SARS-CoV-2.
- Open Access
Defining the Immunomodulatory Determinants of 3-mer Oligonucleotides on TLR7 and TLR8 sensing
Chemical modifications such as 2′-O-methyl (2′-OMe) are central to the efficacy and tolerability of RNA therapeutics. We recently identified that 2′-OMe RNA fragments as short as three nucleotides can exert opposing effects on Toll-like receptor 8 (TLR8) sensing in a motif-dependent manner. This discovery raises important considerations for degradation products of chemically modified RNA therapeutics, which may generate such immunologically active fragments. Here, leveraging their short length, we systematically map how base and sugar modifications within 3-mer oligonucleotides regulate TLR7 and TLR8 responses, and we resolve the structural basis for both TLR8 potentiation and TLR7/8 antagonism by RNA fragments. Building on these insights, we report the development of a dual TLR7/8 inhibitory oligonucleotide with therapeutic potential in autoimmune disease. Together, these findings provide unprecedented resolution of the immunomodulatory properties of oligonucleotide modifications on TLR7/8 and establish 3-mer oligonucleotides as the shortest functional class of RNA therapeutics described to date.
Open AccessDefining the Immunomodulatory Determinants of 3-mer Oligonucleotides on TLR7 and TLR8 sensing
Chemical modifications such as 2′-O-methyl (2′-OMe) are central to the efficacy and tolerability of RNA therapeutics. We recently identified that 2′-OMe RNA fragments as short as three nucleotides can exert opposing effects on Toll-like receptor 8 (TLR8) sensing in a motif-dependent manner. This discovery raises important considerations for degradation products of chemically modified RNA therapeutics, which may generate such immunologically active fragments. Here, leveraging their short length, we systematically map how base and sugar modifications within 3-mer oligonucleotides regulate TLR7 and TLR8 responses, and we resolve the structural basis for both TLR8 potentiation and TLR7/8 antagonism by RNA fragments. Building on these insights, we report the development of a dual TLR7/8 inhibitory oligonucleotide with therapeutic potential in autoimmune disease. Together, these findings provide unprecedented resolution of the immunomodulatory properties of oligonucleotide modifications on TLR7/8 and establish 3-mer oligonucleotides as the shortest functional class of RNA therapeutics described to date.
- Open Access
- 26 June 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (13) , 6171
Comprehensive Meta-Analysis of Differentially Expressed Proteins in Cerebrospinal Fluid Associated with Multiple Sclerosis
To advance our understanding of multiple sclerosis (MS), accurate identification of protein expression profiles as biomarkers for MS in cerebrospinal fluid (CSF) is critical. However, proteomic studies investigating MS have yielded inconsistent findings due to variability in sample sizes, diagnostic criteria, and data processing methods. We aimed to tackle these challenges by performing a thorough meta-analysis of proteomics datasets sourced from multiple independent studies. We conducted a thorough database search to gather all relevant studies using appropriate keywords. We screened articles using defined inclusion and exclusion criteria, and finally, six studies were included. We retrieved and combined data from five CSF datasets for discovery and two additional datasets for validation in 368 MS patients and controls. After data preprocessing, we calculated Z-scores for all datasets and for the integrated dataset. We used logistic regression models using training and validation datasets. We identified 11 differentially expressed proteins in the integrated dataset, revealing significant alterations in key pathways involved in immune response, neuroinflammation, and synaptic function. Notably, IGKC exhibited strong diagnostic potential, with an AUROC of 0.81. These findings highlight the value of re-analysing publicly available proteomics data to develop robust biomarker panels for MS diagnosis.
- 26 June 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (13) , 6171
Open AccessComprehensive Meta-Analysis of Differentially Expressed Proteins in Cerebrospinal Fluid Associated with Multiple Sclerosis
To advance our understanding of multiple sclerosis (MS), accurate identification of protein expression profiles as biomarkers for MS in cerebrospinal fluid (CSF) is critical. However, proteomic studies investigating MS have yielded inconsistent findings due to variability in sample sizes, diagnostic criteria, and data processing methods. We aimed to tackle these challenges by performing a thorough meta-analysis of proteomics datasets sourced from multiple independent studies. We conducted a thorough database search to gather all relevant studies using appropriate keywords. We screened articles using defined inclusion and exclusion criteria, and finally, six studies were included. We retrieved and combined data from five CSF datasets for discovery and two additional datasets for validation in 368 MS patients and controls. After data preprocessing, we calculated Z-scores for all datasets and for the integrated dataset. We used logistic regression models using training and validation datasets. We identified 11 differentially expressed proteins in the integrated dataset, revealing significant alterations in key pathways involved in immune response, neuroinflammation, and synaptic function. Notably, IGKC exhibited strong diagnostic potential, with an AUROC of 0.81. These findings highlight the value of re-analysing publicly available proteomics data to develop robust biomarker panels for MS diagnosis.
- Open Access
- 16 September 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (9) , e0310565
Peptide nucleic acids can form hairpins and bind RNA-binding proteins
RNA-binding proteins (RBPs) are a major class of proteins that interact with RNAs to change their fate or function. RBPs and the ribonucleoprotein complexes they constitute are involved in many essential cellular processes. In many cases, the molecular details of RBP:RNA interactions differ between viruses, prokaryotes and eukaryotes, making prokaryotic and viral RBPs good potential drug targets. However, targeting RBPs with small molecules has so far been met with limited success as RNA-binding sites tend to be extended, shallow and dynamic with a mixture of charged, polar and hydrophobic interactions. Here, we show that peptide nucleic acids (PNAs) with nucleic acid-like binding properties and a highly stable peptide-like backbone can be used to target some RBPs. We have designed PNAs to mimic the short RNA stem-loop sequence required for the initiation of prokaryotic signal recognition particle (SRP) assembly, a target for antibiotics development. Using a range of biophysical and biochemical assays, the designed PNAs were demonstrated to fold into a hairpin structure, bind the targeted protein and compete with the native RNA hairpin to inhibit SRP formation. To show the applicability of PNAs against other RBPs, a PNA was also shown to bind Nsp9 from SARS-CoV-2, a protein that exhibits non-sequence-specific RNA binding but preferentially binds hairpin structures. Taken together, our results support that PNAs can be a promising class of compounds for targeting RNA-binding activities in RBPs.
- 16 September 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (9) , e0310565
Open AccessPeptide nucleic acids can form hairpins and bind RNA-binding proteins
RNA-binding proteins (RBPs) are a major class of proteins that interact with RNAs to change their fate or function. RBPs and the ribonucleoprotein complexes they constitute are involved in many essential cellular processes. In many cases, the molecular details of RBP:RNA interactions differ between viruses, prokaryotes and eukaryotes, making prokaryotic and viral RBPs good potential drug targets. However, targeting RBPs with small molecules has so far been met with limited success as RNA-binding sites tend to be extended, shallow and dynamic with a mixture of charged, polar and hydrophobic interactions. Here, we show that peptide nucleic acids (PNAs) with nucleic acid-like binding properties and a highly stable peptide-like backbone can be used to target some RBPs. We have designed PNAs to mimic the short RNA stem-loop sequence required for the initiation of prokaryotic signal recognition particle (SRP) assembly, a target for antibiotics development. Using a range of biophysical and biochemical assays, the designed PNAs were demonstrated to fold into a hairpin structure, bind the targeted protein and compete with the native RNA hairpin to inhibit SRP formation. To show the applicability of PNAs against other RBPs, a PNA was also shown to bind Nsp9 from SARS-CoV-2, a protein that exhibits non-sequence-specific RNA binding but preferentially binds hairpin structures. Taken together, our results support that PNAs can be a promising class of compounds for targeting RNA-binding activities in RBPs.
- Open Access
2’-O-Methyl-guanosine 3-base RNA fragments mediate essential natural TLR7/8 antagonism
Recognition of RNA fragments by Toll-like receptors (TLR) 7 and 8 is a key contributor to the initiation of a protective innate immune response against pathogens. A long-standing enigma is how degradation products of host RNAs, generated by the daily phagocytic clearance of billions of apoptotic cells, fail to activate TLR7 and TLR8 signalling 1 . Here, we report that select 2’-O-methyl (2’-Ome) guanosine RNA fragments as short as 3 bases, including those derived from host-RNAs, are potent TLR7 and TLR8 antagonists that reduce TLR7 sensing in vivo . Mechanistically, antagonistic fragments are directed towards a distinct binding site on these proteins by 5’-end 2’-Ome guanosine. Our results indicate that host-RNAs evade detection by TLR7/8 due to a pool of abundant host ribosomal 2’-Ome-modified RNA fragments that naturally antagonize TLR7 and TLR8 sensing to avoid auto-immunity. Crucially, rare TLR7 and TLR8 mutations located at this antagonistic site decrease the inhibitory activity of 2’-Ome guanosine RNA fragments and lead to auto-immunity in patients. Our findings also establish that select chemically synthesised 3-base oligonucleotides can harness the protective anti-inflammatory activity of this natural immune checkpoint for therapeutic targeting of TLR7-driven diseases. One Sentence Summary: Short 2’-O-Methyl RNA fragments are natural TLR7/8 antagonists
Open Access2’-O-Methyl-guanosine 3-base RNA fragments mediate essential natural TLR7/8 antagonism
Recognition of RNA fragments by Toll-like receptors (TLR) 7 and 8 is a key contributor to the initiation of a protective innate immune response against pathogens. A long-standing enigma is how degradation products of host RNAs, generated by the daily phagocytic clearance of billions of apoptotic cells, fail to activate TLR7 and TLR8 signalling 1 . Here, we report that select 2’-O-methyl (2’-Ome) guanosine RNA fragments as short as 3 bases, including those derived from host-RNAs, are potent TLR7 and TLR8 antagonists that reduce TLR7 sensing in vivo . Mechanistically, antagonistic fragments are directed towards a distinct binding site on these proteins by 5’-end 2’-Ome guanosine. Our results indicate that host-RNAs evade detection by TLR7/8 due to a pool of abundant host ribosomal 2’-Ome-modified RNA fragments that naturally antagonize TLR7 and TLR8 sensing to avoid auto-immunity. Crucially, rare TLR7 and TLR8 mutations located at this antagonistic site decrease the inhibitory activity of 2’-Ome guanosine RNA fragments and lead to auto-immunity in patients. Our findings also establish that select chemically synthesised 3-base oligonucleotides can harness the protective anti-inflammatory activity of this natural immune checkpoint for therapeutic targeting of TLR7-driven diseases. One Sentence Summary: Short 2’-O-Methyl RNA fragments are natural TLR7/8 antagonists
- Open Access
- 3 July 2024
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 92 (11) , 1308-1317
A Biochemical and Biophysical Analysis of the Interaction of nsp9 with nsp12 from SARS‐CoV‐2—Implications for Future Drug Discovery Efforts
The ongoing global pandemic of the coronavirus 2019 (COVID‐19) disease is caused by the virus SARS‐CoV‐2, with very few highly effective antiviral treatments currently available. The machinery responsible for the replication and transcription of viral RNA during infection is made up of several important proteins. Two of these are nsp12, the catalytic subunit of the viral polymerase, and nsp9, a cofactor of nsp12 involved in the capping and priming of viral RNA. While several recent studies have determined the structural details of the interaction of nsp9 with nsp12 in the context of RNA capping, very few biochemical or biophysical details are currently available. In this study, we have used a combination of surface plasmon resonance (SPR) experiments, size exclusion chromatography (SEC) experiments, and biochemical assays to identify specific nsp9 residues that are critical for nsp12 binding as well as RNAylation, both of which are essential for the RNA capping process. Our data indicate that nsp9 dimerization is unlikely to play a significant functional role in the virus. We confirm that a set of recently discovered antiviral peptides inhibit nsp9–nsp12 interaction by specifically binding to nsp9; however, we find that these peptides do not impact RNAylation. In summary, our results have important implications for future drug discovery efforts to combat SARS‐CoV‐2 and any newly emerging coronaviruses.
- 3 July 2024
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 92 (11) , 1308-1317
Open AccessA Biochemical and Biophysical Analysis of the Interaction of nsp9 with nsp12 from SARS‐CoV‐2—Implications for Future Drug Discovery Efforts
The ongoing global pandemic of the coronavirus 2019 (COVID‐19) disease is caused by the virus SARS‐CoV‐2, with very few highly effective antiviral treatments currently available. The machinery responsible for the replication and transcription of viral RNA during infection is made up of several important proteins. Two of these are nsp12, the catalytic subunit of the viral polymerase, and nsp9, a cofactor of nsp12 involved in the capping and priming of viral RNA. While several recent studies have determined the structural details of the interaction of nsp9 with nsp12 in the context of RNA capping, very few biochemical or biophysical details are currently available. In this study, we have used a combination of surface plasmon resonance (SPR) experiments, size exclusion chromatography (SEC) experiments, and biochemical assays to identify specific nsp9 residues that are critical for nsp12 binding as well as RNAylation, both of which are essential for the RNA capping process. Our data indicate that nsp9 dimerization is unlikely to play a significant functional role in the virus. We confirm that a set of recently discovered antiviral peptides inhibit nsp9–nsp12 interaction by specifically binding to nsp9; however, we find that these peptides do not impact RNAylation. In summary, our results have important implications for future drug discovery efforts to combat SARS‐CoV‐2 and any newly emerging coronaviruses.
- Open Access
- 6 November 2023
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 92 (3) , 418-426
A structural analysis of the nsp9 protein from the coronavirus MERS CoV reveals a conserved RNA binding interface
Middle East respiratory syndrome coronavirus (MERS CoV) and severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) are RNA viruses from the Betacoronavirus family that cause serious respiratory illness in humans. One of the conserved non-structural proteins encoded for by the coronavirus family is non-structural protein 9 (nsp9). Nsp9 plays an important role in the RNA capping process of the viral genome, where it is covalently linked to viral RNA (known as RNAylation) by the conserved viral polymerase, nsp12. Nsp9 also directly binds to RNA; we have recently revealed a distinct RNA recognition interface in the SARS CoV-2 nsp9 by using a combination of nuclear magnetic resonance spectroscopy and biolayer interferometry. In this study, we have utilized a similar methodology to determine a structural model of RNA binding of the related MERS CoV. Based on these data, we uncover important similarities and differences to SARS CoV-2 nsp9 and other coronavirus nsp9 proteins. Our findings that replacing key RNA binding residues in MERS CoV nsp9 affects RNAylation efficiency indicate that recognition of RNA may play a role in the capping process of the virus.
- 6 November 2023
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 92 (3) , 418-426
Open AccessA structural analysis of the nsp9 protein from the coronavirus MERS CoV reveals a conserved RNA binding interface
Middle East respiratory syndrome coronavirus (MERS CoV) and severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) are RNA viruses from the Betacoronavirus family that cause serious respiratory illness in humans. One of the conserved non-structural proteins encoded for by the coronavirus family is non-structural protein 9 (nsp9). Nsp9 plays an important role in the RNA capping process of the viral genome, where it is covalently linked to viral RNA (known as RNAylation) by the conserved viral polymerase, nsp12. Nsp9 also directly binds to RNA; we have recently revealed a distinct RNA recognition interface in the SARS CoV-2 nsp9 by using a combination of nuclear magnetic resonance spectroscopy and biolayer interferometry. In this study, we have utilized a similar methodology to determine a structural model of RNA binding of the related MERS CoV. Based on these data, we uncover important similarities and differences to SARS CoV-2 nsp9 and other coronavirus nsp9 proteins. Our findings that replacing key RNA binding residues in MERS CoV nsp9 affects RNAylation efficiency indicate that recognition of RNA may play a role in the capping process of the virus.
- Open Access
- 26 September 2023
- Published by Wiley in Protein Science
- Vol. 32 (10) , e4782
The molecular details of a novel phosphorylation‐dependent interaction between MRN and the SOSS complex
The repair of double‐strand DNA breaks (DSBs) by homologous recombination is crucial in the maintenance of genome integrity. While the key role of the Mre11‐Rad50‐Nbs1 (MRN) complex in repair is well known, hSSB1 (SOSSB and OBFC2B), one of the main components of the sensor of single‐stranded DNA (SOSS) protein complex, has also been shown to rapidly localize to DSB breaks and promote repair. We have previously demonstrated that hSSB1 binds directly to Nbs1, a component of the MRN complex, in a DNA damage‐independent manner. However, recruitment of the MRN complex has also been demonstrated by an interaction between Integrator Complex Subunit 3 (INTS3; also known as SOSSA), another member of the SOSS complex, and Nbs1. In this study, we utilize a combined approach of in silico, biochemical, and functional experiments to uncover the molecular details of INTS3 binding to Nbs1. We demonstrate that the forkhead‐associated domain of Nbs1 interacts with INTS3 via phosphorylation‐dependent binding to INTS3 at Threonine 592, with contributions from Serine 590. Based on these data, we propose a model of MRN recruitment to a DSB via INTS3.
- 26 September 2023
- Published by Wiley in Protein Science
- Vol. 32 (10) , e4782
Open AccessThe molecular details of a novel phosphorylation‐dependent interaction between MRN and the SOSS complex
The repair of double‐strand DNA breaks (DSBs) by homologous recombination is crucial in the maintenance of genome integrity. While the key role of the Mre11‐Rad50‐Nbs1 (MRN) complex in repair is well known, hSSB1 (SOSSB and OBFC2B), one of the main components of the sensor of single‐stranded DNA (SOSS) protein complex, has also been shown to rapidly localize to DSB breaks and promote repair. We have previously demonstrated that hSSB1 binds directly to Nbs1, a component of the MRN complex, in a DNA damage‐independent manner. However, recruitment of the MRN complex has also been demonstrated by an interaction between Integrator Complex Subunit 3 (INTS3; also known as SOSSA), another member of the SOSS complex, and Nbs1. In this study, we utilize a combined approach of in silico, biochemical, and functional experiments to uncover the molecular details of INTS3 binding to Nbs1. We demonstrate that the forkhead‐associated domain of Nbs1 interacts with INTS3 via phosphorylation‐dependent binding to INTS3 at Threonine 592, with contributions from Serine 590. Based on these data, we propose a model of MRN recruitment to a DSB via INTS3.
- Open Access
- 28 October 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (11) , 1585
Essential Role of Histidine for Rapid Copper(II)-Mediated Disassembly of Neurokinin B Amyloid
Neurokinin B is a tachykinin peptide involved in a diverse range of neuronal functions. It rapidly forms an amyloid, which is considered physiologically important for efficient packing into dense core secretory vesicles within hypothalamic neurons. Disassembly of the amyloid is thought to require the presence of copper ions, which interact with histidine at the third position in the peptide sequence. However, it is unclear how the histidine is involved in the amyloid structure and why copper coordination can trigger disassembly. In this work, we demonstrate that histidine contributes to the amyloid structure via π-stacking interactions with nearby phenylalanine residues. The ability of neurokinin B to form an amyloid is dependent on any aromatic residue at the third position in the sequence; however, only the presence of histidine leads to both amyloid formation and rapid copper-induced disassembly.
- 28 October 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (11) , 1585
Open AccessEssential Role of Histidine for Rapid Copper(II)-Mediated Disassembly of Neurokinin B Amyloid
Neurokinin B is a tachykinin peptide involved in a diverse range of neuronal functions. It rapidly forms an amyloid, which is considered physiologically important for efficient packing into dense core secretory vesicles within hypothalamic neurons. Disassembly of the amyloid is thought to require the presence of copper ions, which interact with histidine at the third position in the peptide sequence. However, it is unclear how the histidine is involved in the amyloid structure and why copper coordination can trigger disassembly. In this work, we demonstrate that histidine contributes to the amyloid structure via π-stacking interactions with nearby phenylalanine residues. The ability of neurokinin B to form an amyloid is dependent on any aromatic residue at the third position in the sequence; however, only the presence of histidine leads to both amyloid formation and rapid copper-induced disassembly.